IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BALOTTA, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.268
NA - Nord America 8.126
AS - Asia 6.852
SA - Sud America 670
AF - Africa 192
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 7
Totale 25.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.744
GB - Regno Unito 3.437
CN - Cina 2.130
SG - Singapore 2.070
DE - Germania 1.437
IT - Italia 1.338
SE - Svezia 678
RU - Federazione Russa 647
HK - Hong Kong 529
BR - Brasile 488
VN - Vietnam 474
BD - Bangladesh 431
FR - Francia 372
CA - Canada 311
TR - Turchia 278
IN - India 272
IE - Irlanda 257
UA - Ucraina 256
NL - Olanda 243
KR - Corea 227
FI - Finlandia 189
EU - Europa 111
ID - Indonesia 107
PL - Polonia 84
JP - Giappone 71
CO - Colombia 63
CI - Costa d'Avorio 58
BE - Belgio 56
GR - Grecia 47
AR - Argentina 46
AT - Austria 39
AU - Australia 37
ZA - Sudafrica 36
MX - Messico 35
IQ - Iraq 34
TW - Taiwan 34
DK - Danimarca 30
ES - Italia 30
PK - Pakistan 26
PH - Filippine 24
CH - Svizzera 22
EC - Ecuador 21
MA - Marocco 21
BG - Bulgaria 19
VE - Venezuela 17
RO - Romania 16
TH - Thailandia 16
UZ - Uzbekistan 16
NO - Norvegia 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
IR - Iran 13
PT - Portogallo 13
ET - Etiopia 12
MY - Malesia 10
OM - Oman 10
IL - Israele 8
TN - Tunisia 8
CZ - Repubblica Ceca 7
JM - Giamaica 7
KE - Kenya 7
PE - Perù 7
DZ - Algeria 6
GH - Ghana 6
JO - Giordania 6
LV - Lettonia 6
NG - Nigeria 6
AZ - Azerbaigian 5
BO - Bolivia 5
EG - Egitto 5
KZ - Kazakistan 5
LB - Libano 5
MK - Macedonia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PY - Paraguay 5
AL - Albania 4
HN - Honduras 4
HU - Ungheria 4
NI - Nicaragua 4
SL - Sierra Leone 4
TZ - Tanzania 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
KW - Kuwait 3
LT - Lituania 3
LU - Lussemburgo 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
UG - Uganda 3
AM - Armenia 2
BB - Barbados 2
CM - Camerun 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
Totale 25.225
Salva come PNG Salva come JPEG
Città #
Southend 3.196
Singapore 1.194
Frankfurt am Main 773
Ashburn 727
Chandler 561
Hong Kong 497
Seattle 487
Milan 473
San Jose 460
Fairfield 389
Beijing 364
Wilmington 318
Princeton 289
Dublin 256
Woodbridge 239
Council Bluffs 237
Houston 228
Dallas 225
Ann Arbor 192
New York 178
Los Angeles 176
Santa Clara 167
Jacksonville 161
Dearborn 158
Toronto 147
Redmond 142
Boardman 132
Cambridge 130
Guangzhou 128
Hanoi 126
Lauterbourg 125
Nanjing 122
Ho Chi Minh City 121
Bengaluru 104
Mountain View 100
Des Moines 96
Ottawa 96
Moscow 92
Buffalo 91
Sakarya 91
Shanghai 80
Serra 79
Columbus 78
The Dalles 76
Jakarta 72
Phoenix 72
Rome 72
Warsaw 70
Hanover 67
Shenyang 62
Helsinki 61
Jinan 58
Tokyo 58
Abidjan 57
Andover 57
Somerville 54
Brussels 46
São Paulo 46
Bogotá 45
Nuremberg 44
Cangzhou 43
Istanbul 43
Redwood City 43
Tianjin 41
Hefei 40
Munich 39
Dong Ket 38
Changsha 37
Berlin 36
Hebei 34
Mumbai 34
Shenzhen 34
Turin 34
Athens 33
San Diego 33
Falls Church 32
Pisa 31
Zhengzhou 31
Seoul 29
Hangzhou 26
Nanchang 26
Naples 26
Washington 26
Grafing 25
Eitensheim 24
Kunming 24
Atlanta 23
Haiphong 23
Jiaxing 22
Fuzhou 21
Margão 20
Fremont 19
Chennai 18
Silver Spring 18
Vienna 18
Bitonto 17
Da Nang 17
London 17
Piscataway 16
Brasília 15
Totale 16.168
Salva come PNG Salva come JPEG
Nome #
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 580
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μl in Europe and North America: A pooled cohort observational study 505
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 476
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms 417
Identification of two distinct subsets of long-term nonprogressors with divergent viral activity by stromal-derived factor 1 chemokine gene polymorphism analysis 363
Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region : outcome after treatment in recently infected individuals 354
Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection 352
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 321
Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004–2014 319
Prevalence of HIV-1 resistant strains in recent seroconverters 314
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts : Data from the Icona Foundation Cohort 295
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 295
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 288
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy 287
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 284
Role of CCR5, CCR2 and SDF-1 gene polymorphisms in a population of HIV-1 infected individuals 282
Genomic characterisation and phylogenetic analysis of SARS-COV-2 in Italy 281
Local epidemics gone viral : evolution and diffusion of the Italian HIV-1 recombinant form CRF60_BC 279
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades 279
Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection 277
HIV-1 A1 subtype epidemic in Italy originated from Africa and Eastern Europe and shows a high frequency of transmission chains involving intravenous drug users 276
Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection 275
Epidemiological spread of drug-resistant HIV-1 strains 255
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy 254
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 244
Transmission of Resistant HIV-1 Variants and Epidemiological Chains in Italian Newly Diagnosed Individuals 239
High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype 239
Telbivudine in the treatment of chronic hepatitis B : experience in HIV-1 infected patients naïve for antiretroviral therapy 238
Non-AIDS defining cancers in the D:A:D Study-time trends and predictors of survival : a cohort study 237
Minor Mutations in HIV-Protease at Baseline and Appearance of Primary Mutation 90M in Patients Failing Their First Protease-Inhibitor Antiretroviral Regimens 236
The global spread of HIV-1 subtype B epidemic 233
Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters 232
Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy 228
Cellular HIV-1 DNA levels in drug sensitive strains are equivalent to those in drug resistant strains in newly-diagnosed patients in Europe 225
Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a multicenter cohort of HIV-1-infected Italian patients with virologic failure 224
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 224
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors 218
HIV-1 Subtype F1 Epidemiological Networks among Italian Heterosexual Males Are Associated with Introduction Events from South America 217
Identification of a new HIV-1 BC circulating recombinant form (CRF60_BC) in Italian young men having sex with men 214
AIDS in a long-term HIV-1-infected patient with a stable high CD4+ cell count and conserved CD4+CD45RO+ subpopulation 213
HIV type 1 phenotype correlates with the stage of infection in vertically infected children 213
Viral load, viral phenotype modification, zidovudine susceptibility and reverse transcriptase mutations during the first 6 months of zidovudine monotherapy in HIV-1-infected people 211
Evidence of differential selection of HIV-1 variants carrying drug-resistant mutations in seroconverters 208
Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy 206
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy 205
Trends and predictors of transmitted drug resistance (TDR) and clusters with TDR in a local Belgian HIV-1 epidemic 201
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 201
Virologic and immunologic markers of disease progression in pediatric HIV infection 197
Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS 197
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient 197
Comparable biological and molecular determinants in HIV type 1-infected long-term nonprogressors and recently infected individuals 197
Identification of a possible ancestor of the subtype A1 HIV-1 variant circulating in the Former Soviet Union 196
Chemokine production in HIV-seropositive long-term asymptomatic individuals 195
High frequency of man having sex with man with unknown duration of infection in epidemiological networks involving primary resistance in HIV 1 naive individuals 195
A Simple model of HIV epidemic in Italy: The role of the antiretroviral treatment 195
Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium 195
Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe : Implications for clinical management 189
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. 185
Evolution of HIV-1 transmitted drug resistance in Italy in the 2007–2014 period : a weighted analysis 185
Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland. 184
Limited cross-border infections in patients newly diagnosed with HIV in Europe 184
The prognostic value to predict virological outcomes of 14 distinct systems used to interpret the results of genotypic HIV-1 drug resistance testing in untreated patients starting their first HAART 183
Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors 183
Transmission of drug-resistant HIV-1 in Europe remains limited to single classes 183
Differences in the frequency of minor substitutions between HIV-1 subtypes and their potential impact on the genetic barrier for resistance to protease inhibitors 180
Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure 180
Local and global spatio-temporal dynamics of HIV-1 subtype F1 180
Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection 179
Overview on HIV-1-related drug resistance: from theory to clinical practice 179
Patterns of transmitted HIV drug resistance in Europe vary by risk group 178
Evolution of Resistance-Associated Variants of All-Oral Direct-Acting Antiviral Therapy of Hepatitis C in a Clinical Setting 177
Durability of Humoral Responses after the Second Dose of mRNA BNT162b2 Vaccine in Residents of a Long Term Care Facility 176
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives : Data from the ICONA cohort 175
Transmission of drug-resistant HIV-1 is stabilizing in Europe 173
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics 173
Variability in the interpretation of transmitted genotypic HIV-1 drug resistance and prediction of virological outcomes of the initial HAART by distinct systems 172
Tracing the HIV-1 subtype B mobility in Europe : a phylogeographic approach 169
Global dispersal pattern of HIV-1 CRF01_AE : a genetic trace of human mobility related to heterosexual activities centralized in South-East Asia 168
Antiinflammatory action of salicylates: aspirin is not a prodrug for salicylate against rat carrageenin pleurisy 167
An outbreak of HIV-1 subtype G among Italian injecting drug users 166
Prevalence of HIV-1 primary drug resistance in seroconverters of the ICoNA cohort over the period 1996-2001 164
Origin and evolutionary dynamics of Hepatitis B virus (HBV) genotype E in Madagascar 164
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms : data from seroconverters in the CASCADE collaboration from 1987 to 2003 163
Processivity and drug-dependence of HIV-1 protease : determinants of viral fitness in variants resistant to protease inhibitors 163
Long-term resistance to HIV infection in vertical HIV infection: cytokine production, HIV isolation, and HIV phenotype define long-term resistant hosts 163
Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics 163
Pentoxifylline improves cell-mediated immunity and reduces human immunodeficiency virus (HIV) plasma viremia in asymptomatic HIV-seropositive persons 162
Plasma viremia and virus phenotype are correlates of disease progression in vertically human immunodeficiency virus type 1-infected children 160
Low prevalence of primary mutations associated with drug resistance in antiviral-naive patients at therapy initiation 160
Chemotactic factor and P15E-related chemotaxis inhibitor in human melanoma cell lines with different macrophage content and tumorigenicity in nude mice 153
An outbreak of HIV-1 BC recombinants in Southern Italy 152
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy : Data from the Icona Foundation cohort 152
HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy 151
Antisense phosphorothioate oligodeoxynucleotides targeted to the vpr gene inhibit human immunodeficiency virus type 1 replication in primary human macrophages 148
Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase 147
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy 145
Sero-survey on long-term care facility residents reveals increased risk of sub-optimal antibody response to BNT162b2: implications for breakthrough prevention 145
Neutralizing antibodies response to novel SARS-CoV-2 omicron sublineages in long-term care facility residents after the fourth dose of monovalent BNT162b2 COVID-19 vaccination 145
CD4 count in HIV infection is positively correlated to interferon-gamma and negatively correlated to interleukin-10 in vitro production 142
Clinical and immunological aspects of HIV infection in drug addicts 140
Totale 22.128
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.582
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/20221.729 149 89 65 78 126 97 153 150 224 192 125 281
2022/20232.088 257 212 174 245 218 367 43 121 289 22 90 50
2023/20241.623 34 100 66 48 273 102 142 160 69 165 189 275
2024/20253.525 207 356 127 339 289 145 200 355 210 292 279 726
2025/20266.736 659 322 634 507 617 518 904 341 714 470 830 220
Totale 26.290